End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.88 CNY | -0.33% | -0.39% | -5.20% |
05-30 | Hengrui Pharmaceuticals Gets Nod to Trial Vitiligo Drug | MT |
05-27 | China Grants Clinical Trial Approval for Anti-Cancer Injections | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.20% | 37.65B | |
+39.82% | 734B | |
+32.47% | 591B | |
-7.31% | 350B | |
+14.23% | 315B | |
+0.86% | 276B | |
+13.91% | 238B | |
-6.50% | 204B | |
+8.28% | 206B | |
+4.51% | 161B |
- Stock Market
- Equities
- 600276 Stock
- News Jiangsu Hengrui Medicine Co., Ltd.
- Hengrui Pharmaceuticals Unit Gets China Clinical Trial Approval for Kidney Medication